Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 2599

1.

Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease.

Fidan N, Inci A, Coban M, Ulman C, Kursat S.

J Investig Med. 2016 Apr;64(4):861-6. doi: 10.1136/jim-2015-000043. Epub 2016 Mar 11.

PMID:
26969749
2.

Lupus nephritis: An approach to diagnosis and treatment in South Africa.

Okpechi IG, Ameh OI.

S Afr Med J. 2015 Dec;105(12):1071-4. Review.

PMID:
26933719
3.

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide.

Cernaro V, Santoro D, Lacquaniti A, Costantino G, Visconti L, Buemi A, Buemi M.

Int J Nephrol Renovasc Dis. 2016 Feb 2;9:11-9. doi: 10.2147/IJNRD.S78040. eCollection 2016. Review.

4.

High-phosphorus diet maximizes and low-dose calcitriol attenuates skeletal muscle changes in long-term uremic rats.

Acevedo LM, Lopez I, Peralta-Ramírez A, Pineda C, Chamizo VE, Rodríguez M, Aguilera-Tejero E, Rivero JL.

J Appl Physiol (1985). 2016 Feb 11:jap.00957.2015. doi: 10.1152/japplphysiol.00957.2015. [Epub ahead of print]

PMID:
26869708
5.

Use of denosumab in a dialysis patient with bone metastases from breast cancer and hepatorenal polycystic disease: a case report.

Quiroga García V, Cirauqui Cirauqui B, Tobey Robaina L, López Sisamon D, Hardy-Werbin M, Blanca AB, Margelí Vila M.

Anticancer Drugs. 2016 Jun;27(5):464-9. doi: 10.1097/CAD.0000000000000339.

PMID:
26813866
6.

Mandibular mass in a child on hemodialysis.

Youssef DM, Mohammed FF, Adham T.

Saudi J Kidney Dis Transpl. 2016 Jan;27(1):144-6. doi: 10.4103/1319-2442.174169.

7.

The effects of cinacalcet treatment on bone mineral metabolism, anemia parameters, left ventricular mass index and parathyroid gland volume in hemodialysis patients with severe secondary hyperparathyroidism.

Torun D, Yildiz I, Micozkadioglu H, Nursal GN, Yigit F, Ozelsancak R.

Saudi J Kidney Dis Transpl. 2016 Jan;27(1):15-22. doi: 10.4103/1319-2442.174053.

8.

Patient characteristics, disease burden, and medication use in stage 4 - 5 chronic kidney disease patients.

Wetmore JB, Peng Y, Jackson S, Matlon TJ, Collins AJ, Gilbertson DT.

Clin Nephrol. 2016 Feb;85(2):101-11. doi: 10.5414/CN108626.

PMID:
26636331
9.

[Successful familial kidney transplant in an infant weighing less than 10 kg: case report and review of the literature].

Mourani C, Azar H, Moukarzel M, Gerbaka B, Kallas Chemaly A, Nehme Chelala D.

J Med Liban. 2015 Jul-Sep;63(3):122-5. Review. French.

PMID:
26591190
10.

Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure.

Pulskens WP, Verkaik M, Sheedfar F, van Loon EP, van de Sluis B, Vervloet MG, Hoenderop JG, Bindels RJ; NIGRAM Consortium.

PLoS One. 2015 Nov 13;10(11):e0142510. doi: 10.1371/journal.pone.0142510. eCollection 2015.

11.

Biomarkers of Vitamin D Status and Risk of ESRD.

Rebholz CM, Grams ME, Lutsey PL, Hoofnagle AN, Misialek JR, Inker LA, Levey AS, Selvin E, Hsu CY, Kimmel PL, Vasan RS, Eckfeldt JH, Coresh J; Chronic Kidney Disease Biomarkers Consortium.

Am J Kidney Dis. 2016 Feb;67(2):235-42. doi: 10.1053/j.ajkd.2015.08.026. Epub 2015 Oct 23.

PMID:
26475393
12.

Treatment Failure of Active Vitamin D Therapy in Chronic Kidney Disease: Predictive Factors.

Cozzolino M, Covic A, Martinez-Placencia B, Xynos K.

Am J Nephrol. 2015;42(3):228-36. doi: 10.1159/000441095. Epub 2015 Oct 7.

13.

Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.

Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2128-35. doi: 10.2215/CJN.05220515. Epub 2015 Oct 1.

PMID:
26430087
14.

Prolonged hypophosphatemia following parathyroidectomy in chronic hemodialysis patients.

Altun E, Paydas S, Kaya B, Balal M.

Saudi J Kidney Dis Transpl. 2015 Sep;26(5):976-9. doi: 10.4103/1319-2442.164582.

15.

Hypertension in children with end-stage renal disease.

Roszkowska-Blaim M, Skrzypczyk P.

Adv Med Sci. 2015 Sep;60(2):342-8. doi: 10.1016/j.advms.2015.07.001. Epub 2015 Jul 17. Review.

PMID:
26275711
16.

Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study.

van Ballegooijen AJ, Gansevoort RT, Lambers-Heerspink HJ, de Zeeuw D, Visser M, Brouwer IA, Kema IP, de Borst MH, Bakker SJ, Joosten MM.

Hypertension. 2015 Sep;66(3):563-70. doi: 10.1161/HYPERTENSIONAHA.115.05837. Epub 2015 Jul 20.

PMID:
26195480
17.

A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.

Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, Yue S, Vincenti F.

Transplantation. 2016 Jan;100(1):184-93. doi: 10.1097/TP.0000000000000823.

18.

[FGF23 and Klotho protein--the role in the pathogenesis of hypertension].

Zając M, Rybi-Szumińska A, Wasilewska A.

Wiad Lek. 2015;68(1):67-70. Review. Polish.

PMID:
26094336
19.

Comparison of Serum Vitamin D Levels Among Patients With Chronic Kidney Disease, Patients in Dialysis, and Renal Transplant Patients.

Çankaya E, Bilen Y, Keleş M, Uyanık A, Akbaş M, Güngör A, Arslan Ş, Aydınlı B.

Transplant Proc. 2015 Jun;47(5):1405-7. doi: 10.1016/j.transproceed.2015.04.036.

PMID:
26093729
20.

Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.

Shroff R, Aitkenhead H, Costa N, Trivelli A, Litwin M, Picca S, Anarat A, Sallay P, Ozaltin F, Zurowska A, Jankauskiene A, Montini G, Charbit M, Schaefer F, Wühl E; ESCAPE Trial Group.

J Am Soc Nephrol. 2016 Jan;27(1):314-22. doi: 10.1681/ASN.2014090947. Epub 2015 Jun 11.

PMID:
26069294
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk